Abstract
To the Editor—We read with interest the article by Minchella and colleagues, who prospectively studied anemia (baseline prevalence, 67%) in patients with tuberculosis in The Gambia [1]. Although the most common etiology was immune-mediated anemia of chronic disease (ACD), iron deficiency anemia (IDA) and combined anemia (ACD + IDA) were also frequently observed. Whereas ACD typically resolved with successful tuberculosis treatment alone, IDA and ACD +IDA did not. At baseline, patients had high serum levels of hepcidin, the master regulator of iron homeostasis. Such high levels are predictive of nonresponsiveness to oral iron replacement therapy [2] due to its combined effects of inhibiting duodenal iron absorption and causing iron sequestration. However, since levels reduced to near normal after 2 months of tuberculosis treatment, the authors suggested that iron-based interventions for anemia might be effective from this time-point.

This publication has 9 references indexed in Scilit: